Call for Abstracts of Free Paper

Call for abstracts for International Session in the JSPRS2027 Annual Meeting Submission Period

Open	Tuesday, September 1, 2026 at 12:00 PM (JST, UTC+9)
Close	Wednesday, October 7, 2026 at 12:00 PM (JST, UTC+9)

Abstract submissions must be completed online by clicking the button at the bottom of this page.
Upon completion of your submission, a confirmation email will be sent to your registered email address. Please be sure to check it. If you do not receive the confirmation email, please check your other folders (such as your spam/junk folder) and your inbox filter settings before contacting the Congress Secretariat (E-mail: jsprs70@gakkai.co.jp).
Your Abstract Submission ID and password are required to view, modify, or withdraw your submission. Please log in using the "View / Modify / Delete" button at the bottom of this page. Your Abstract Submission ID is included in the confirmation email.
If you have any questions, please contact the Congress Secretariat (E-mail: jsprs70@gakkai.co.jp).

The first author listed for each abstract serves as the presenting author and as the primary contact for all correspondence regarding the abstract.
The presenting author must be one of the co-authors listed on the submitted abstract.
The presenting author is responsible for ensuring that all authors have read the abstract and agreed to be co-authors.

Each speaker will have 10 minutes for presentation. Please time your talk for 8 minutes, and 2 minutes for questions and answers.

Type of presentation in the JSPRS2027 is only ORAL PRESENTATION.

Your abstract must include:

Your Name (Name of the First Author)
Name(s) of Affiliation (This will be printed in the Program Book)
Name(s) and Affiliation(s) for Co-Authors (up to 8 people)
Contact E-mail Address
Title of Abstract (100 one-byte characters)
The abstract title should be brief and clearly indicate the nature of the presentation. Do not put a period at the end of the title.
Abstract Body (within 1,600 one-byte characters)
The entire body of the abstract must not exceed 250 words.
Spaces are not included in this number. No tables or diagrams should be included.
Category
Please select 1 or 2 Categories to your abstract. (Categories will not be printed in the Program Book; they will be used as a reference for peer review.)

[Category]

01	Aesthetic	14	Head & Neck Reconstruction
02	Aesthetic Breast Surgery	15	Microsurgery / Supermicrosurgery
03	Benign and Malignant Tumors	16	Migraine Surgery
04	Blepharoplasty	17	Laser
05	Breast Reconstruction	18	Liposuction / Body Contouring
06	Burn	19	Lymphedema / Lymphatic Surgery
07	Cell-Based Therapy	20	Otoplasty
08	Chronic Wound	21	Regenerative Medicine
09	Cranio- / Maxillofacial Surgery	22	Rhinoplasty
10	Facial trauma	23	Robotic Surgery
11	Fat grafting	24	Scar / Hypertrophic Scar / Keloid
12	Gender Confirmation Medicine/Surgery, Sex Reassignment Surgery	25	Wound Healing
13	Hand	26	Miscellaneous

After the submission deadline, all completed and eligible abstracts will be made available to the Organizing Review Committees for blinded review and scoring, and final decisions will be made in early January 2027.
Incomplete abstracts will not be reviewed.
All abstracts submitted will be considered eligible for one presentation (ORAL PRESENTATION).

Notification of Acceptance (by E-mail)	Email will be sent in the beginning of January

Notification regarding acceptance or rejection of abstracts will be sent to the first (presenting) author in early January 2027 by e-mail. Therefore, providing an accurate email address is essential. Rejection notifications will also be sent at that time.
If you have not received the e-mail, please contact Congress Secretariat shown at the bottom of this page.

Conflict-Of-Interest (COI) Policy requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict.
Please disclose any relationships or circumstances that might affect or appear to affect the research presented. These relationships include you or any individual with whom you directly share income.
All authors and co-authors are required to provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author's view on the presentation; including relationships with pharmaceutical companies, or other companies whose products or services are related to the subject matter of the presentation topic. If no relevant relationships exist, this must be stated as well.

All abstracts must be submitted online through the abstract submission system below.

CONGRESS SECRETARIAT: Congress Organizing Service Inc.; 7-3-101, Uguisudani-cho, Shibuya-ku, Tokyo 150-0032, Japan; E-mail: jsprs70@gakkai.co.jp